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Abstract
Background: The signaling cascades that direct the morphological differentiation of the vascular system during
early embryogenesis are not well defined. Several signaling pathways, including Notch and VEGF signaling, are
critical for the formation of the vasculature in the mouse. To further understand the role of Notch signaling during
endothelial differentiation and the genes regulated by this pathway, both loss-of-function and gain-of-function
approaches were analyzed in vivo.
Results: Conditional transgenic models were used to expand and ablate Notch signaling in the early embryonic
endothelium. Embryos with activated Notch1 signaling in the vasculature displayed a variety of defects, and died
soon after E10.5. Most notably, the extraembryonic vasculature of the yolk sac displayed remodeling differentiation
defects, with greatly enlarged lumens. These phenotypes were distinct from endothelial loss-of-function of RBPJ, a
transcriptional regulator of Notch activity. Gene expression analysis of RNA isolated from the yolk sac endothelia of
transgenic embryos indicated aberrant expression in a variety of genes in these models. In particular, a variety of
secreted factors, including VEGF and TGF-b family members, displayed coordinate expression defects in the loss-of-
function and gain-of-function models.
Conclusions: Morphological analyses of the in vivo models confirm and expand the understanding of Notch
signaling in directing endothelial development, specifically in the regulation of vessel diameter in the intra- and
extraembryonic vasculature. Expression analysis of these in vivo models suggests that the vascular differentiation
defects may be due to the regulation of key genes through the Notch-RBPJ signaling axis. A number of these
genes regulated by Notch signaling encode secreted factors, suggesting that Notch signaling may mediate
remodeling and vessel diameter in the extraembryonic yolk sac via autocrine and paracrine cell communication.
We propose a role for Notch signaling in elaborating the microenvironment of the nascent arteriole, suggesting
novel regulatory connections between Notch signaling and other signaling pathways during endothelial
differentiation.
Background
The formation of the vascular system is essential for
nutrient and waste transport in the growing embryo. In
mice, the developing vasculature initially forms in
intraembryonic and extraembryonic regions. In the
extraembryonic yolk sac at approximately E7.0-7.5,
angioblasts are formed from the differentiation of meso-
dermal cells. These angioblasts differentiate into
endothelial cells, elaborate cell contacts, and lumenize
into simple tubes; resulting in the formation of a
capillary plexus network [1,2]. The simple plexus of the
yolk sac is remodeled and refined after E8.5 to form the
larger diameter vessels. During this process, extensive
movements of endothelial cells within the plexus occur
through a process termed intussusceptive arborization
[3], reallocating cells from the capillaries to larger ves-
sels, to assemble a more complex vasculature network
[4,5]. This process forms the vitelline arteriole and
venule, which participate in the contiguous blood flow
with the embryonic vasculature, concomitant with the
initiation of flow after E9.0. Although likely context
dependent, vessel remodeling also occurs in the adult,
during wound healing, reproductive cycling, and tumor
progression [6]. More work needs to be done to define
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vascular differentiation in the various sites of develop-
ment and in the adult.
Both vasculogenic and angiogenic processes are highly
regulative, and under the control of a number of signal-
ing pathways, including the vascular endothelial growth
factor (VEGF) pathway, the Notch pathway, and the
transforming growth factor-b (TGF-b) pathway, among
others [7-10]. Notch signaling is an evolutionary con-
served pathway and a determinant of cell fate [11]. Four
Notch receptors (Notch 1-4) exist in mice and human
along with five ligands (Jagged1 and -2, and Dll1, -3,
and -4) [12]. The Notch receptors are activated upon
ligand binding, which initiates the proteolysis of its
intracellular domain (N-ICD). The N-ICD translocates
to the nucleus where it interacts with a family of DNA-
binding proteins, termed recombination signal-binding
protein for immunoglobulin kappa J region (RBPJ; also
known as C-promoter binding factor 1, CBF1), forming
a transcriptional activator complex at the regulatory ele-
ments of target genes, thereby directing changes in gene
expression transcription [12].
Much work has been done to define the roles of the
Notch signaling pathway during vascular differentiation.
Notch1, Notch4, Dll4, Jagged1,a n dJagged2 are all
expressed in the arterial endothelium of vertebrates,
Notch4 being solely expressed in the endothelia of
mouse embryos [13,14]. Mutat i o n si nt h e s eg e n e sl e a d
to defects in the vasculature, many of which are
embryonic lethal. Mutant mice lacking Notch1 do not
survive post E11.5 and harbor defects in vascular remo-
deling in the embryo, yolk sac, and placenta [15]. Dele-
tion of Notch4 has no visible effect and embryos are
viable; however, Notch1
-/-Notch4
-/- double mutants have
more severe vascular phenotypes than the Notch1
-/- and
are embryonic lethal at E9.5 [10,16]. Expression of an
activated form of Notch4 or Notch1 also leads to vascu-
lar defects similar to those seen in the Notch1
-/- and
Notch1
-/-Notch4
-/- mice, as well as embryonic lethality at
~E10 [17,18].
Although Notch clearly plays important roles in the
formation of the early embryonic vasculature, very little
is known about the nature of the downstream targets in
vivo, and how changes in Notch activity elicit the
observed morphological processes. In vitro analysis has
indicated novel Notch targets, including receptors of the
VEGF family, VEGFR-3 (Flt4)a n dV E G F R - 1( Flt1)
[19,20]. Given that several signaling cascades are
required for the morphological differentiation of the
embryonic vasculature, it is likely that these pathways
interact during vascular development.
To better define the activity of Notch signaling in vas-
cular differentiation, a detailed morphological and mole-
cular analysis was performed using developmental
models in which the Notch signaling pathway is altered.
A gain-of-function Notch1 transgenic model showed
that expanded Notch1 signaling in the early vasculature
results in defects in embryo growth, defective differen-
tiation during remodeling of the yolk sac vasculature,
altered patterns of gene expression, and ultimately
embryonic lethality. These phenotypes were compared
to embryos lacking Notch signaling in the endothelia,
via a tissue-specific loss of RBPJ function. Embryos lack-
ing endothelial Rbpj exhibited distinct growth, vascular,
and gene expression defects compared to the Notch1
gain-of-function model. Gene expression analysis in the
yolk sacs of these models demonstrated altered patterns
of expression of a distinct subset of Notch targets. Addi-
tionally, several secreted ligands, including the TGF-b
ligand TGFb2 and the VEGF ligands VEGFC and Pla-
centa Growth Factor (PlGF), were altered in these mod-
els, suggesting a role for an altered VEGF signaling
pathway in the observed phenotypes of these models.
Our data suggest a model in which Notch signaling in
the endothelia is critical for elaborating a specialized
local environment of the developing arterial vasculature,
by influencing the expression of secreted factors, which
may be important in autocrine or paracrine signaling to
direct further morphological differentiation of the vascu-
lature during remodeling.
Results
Conditional transgenesis to modulate Notch signaling in
the early endothelia
To further understand the functions of Notch signaling
in early vascular development, genetic models were
employed to modulate Notch activity in the embryonic
endothelia. These models employ endothelial-specific
Cre-mediated recombination in vivo. To activate and
expand Notch1 signaling in the endothelia, a transgenic
line Rosa
Notch [21] was used, which harbors a NOTCH 1
intracellular domain (N1ICD) cDNA downstream of a
floxed STOP fragment targeted to the Rosa26 locus.
Removal of the STOP cassette through loxP-mediated
recombination, via an endothelial CRE expressing trans-
gene, results in expression of N1ICD in endothelial cells
(designated as EC-N1ICD embryos; Figure 1A). To
delete Notch signaling in the early endothelia, a mouse
line was used which harbors a conditional allele of Rbpj
(Rbpj
f m i c e )[ 2 2 ] .C r o s s i n gt h e s em i c et oe n d o t h e l i a l -
specific CRE transgenic mice results in the deletion of
exons 6 and 7, which encode the DNA binding domain
of Rbpj, abrogating the activity of RBPJ only in endothe-
lial cells (designated as EC-Rbpj-KO embryos; Figure 1B).
The conditional deletion would be predicted to disrupt
both Notch1 and Notch4 signaling, which have known
redundant functions in early embryonic vascular differen-
tiation [10]. Ablation of Rbpj in the endothelia was used
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developing vasculature.
Tie2-Cre [23] or Flk1-Cre [24] transgenic mice were
crossed to either Rosa
Notch or Rbpj
f mice. Each of these
transgenes expresses the Cre recombinase gene and
direct expression principally to the vascular endothe-
lium. Identical phenotypes were observed when the
Flk1-Cre and Tie2-Cre transgenic lines were crossed to
the Rosa
Notch and Rbpj
f models (data not shown). Pre-
vious work has demonstrated that these Cre expressing
transgenes exhibit restricted endothelial expression of
Cre recombinase activity to the endothelial and hemato-
poietic lineages [24]. The early embryonic expression
and recombinase activity of the Tie2-Cre and Flk1-Cre
transgenes was confirmed by crossing these transgenes
to a conditional LacZ reporter [25]. Both transgenes
showed specific expression within the early endothelial
and hematopoietic lineages at E8.5 (Additional File 1).
Regulated Notch signaling is essential for the growth and
development of the early embryo
To activate Notch1 signaling throughout the embryonic
endothelia, female mice heterozygous for the Rosa
Notch
transgene were crossed with male mice hemizygous for
the Tie2-Cre transgene, and the resulting embryos were
analyzed. At E8.5 the EC-N1ICD mice were morphologi-
cally normal and identical to the wild type siblings, with
open neural folds and vascularized allantois characteris-
tic of this time point (Additional File 2). Compared to
stage-matched wild type embryos at E9.5, EC-N1ICD
embryos exhibited an enlarged heart and a reduction in
overall size (Figure 2A,B). Growth defects were much
more pronounced at E10.5 (data not shown), and no
viable embryos were observed after E10.5.
To ablate Notch signaling in the embryo, Tie2-Cre mice
were used in a two-generation cross to generate Tie2-
Cre; Rbpj
f/f embryos (EC-Rbpj-KO), which lack RBPJ
binding activity in the endothelia. The EC-Rbpj-KO
embryos displayed severe growth retardation defects at
E9.5 similar to those observed in the EC-N1ICD
embryos (Figure 2C). The morphological analyses of the
gain-of-function and loss-of-function embryos were con-
sistent with other models [10,17,18,26] and confirmed
that the appropriate Notch signaling in the endothelia of
the early embryo is critical for proper growth and devel-
opment of the embryo.
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Figure 1 Conditional mouse EC-N1ICD and EC-Rbpj-KO transgene constructs. (A) Upon crossing of mice that carry the Rosa
Notch transgene
to a transgenic mouse that expresses CRE in the endothelia, recombination removes the neomycin cassette and induces expression of the
Notch1 intracellular domain only in endothelial cells. (B) Upon crossing of mice that carry the Rbpj
f transgene [22] to a transgenic mouse that
expresses Cre in the endothelia, recombination will remove the neomycin cassette along with exons 6 and 7, which encode for the DNA
binding domains of RBPJ, abrogating the promoter activity of RBPJ only in endothelial cells.
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A detailed comparison of the vasculature was performed
to define the vascular defects in the embryonic and
extraembryonic vasculature of EC-N1ICD and EC-Rbpj-
KO embryos. At E8.5, no overt defects were observed in
the developing vasculature of either the EC-N1ICD or
EC-Rbpj-KO. In particular, the vascular plexus of the
EC-N1ICD yolk sac, visualized by histochemical staining
of endothelial cells with an antibody to PECAM1
(CD31), appeared unaffected when compared to stage-
matched wild type embryos (Additional File 2; data not
shown). The most severe defects were seen in the yolk
sac of the developing embryo beginning at approxi-
mately E9.5. Gross morphological examination of the
vasculature of the yolk sac by whole mount light micro-
s c o p ys h o w e dt h a ta tE 9 . 5t h eE C - N 1 I C Dy o l ks a cw a s
t h es a m es i z ea st h es t a g e - m a t c h e dw i l dt y p ec o n t r o l ;
however these embryos lacked large diameter vessels
(Figure 2D,E), indicating a failure in appropriate blood
vessel remodeling occurring at this time point [5]. The
EC-N1ICD yolk sac vessels did contain blood cells,
although the blood tended to pool near the proximal
end of the yolk sac adjacent to the chorioallantoic plate
(Figure 2E). EC-Rbpj-KO embryos also lacked vascular
remodeling in the yolk sac, failing to form the large
vitelline blood vessels [26] (Figure 2F).
Immunofluorescence of PECAM1 stained E9.5 yolk sac
revealed the failure of this remodeling in both the EC-
N1ICD and EC-Rbpj-KO embryos in greater detail. In
the EC-N1ICD embryos, no distinction between large
caliber vessels and capillaries was observed (Figure 2H);
instead, the vasculature consisted of vessels with an
enlarged surface area with greatly decreased avascular
inter-vessel space compared to wild type controls, as
assessed by lack of PECAM1 expression (’pillars’;F i g u r e
2G,H, arrows). In contrast to the EC-N1ICD vessel
defects, the EC-Rbpj-KO embryos exhibited a qualita-
tively different vessel phenotype in the yolk sac. Although
EC-Rbpj-KO embryos also exhibited a lack of vascular
remodeling, the yolk sac of these embryos displayed
numerous small avascular intervessel spaces (Figure 2I,
arrow). These results indicated that the yolk sac vascula-
ture of the EC-Rbpj-KO embryos failed to form the large
vitelline blood vessels, reminiscent of the simple vascular
plexus seen at E8.5.
Histological sectioning of yolk sac tissue was per-
formed to visualize the vessels in cross-section via
PECAM1 immunochemistry and hematoxylin and eosin
staining. In the wild type yolk sac a distribution of large
and small caliber vessels were present and were filled
with blood cells; in striking contrast, the EC-N1ICD
yolk sac contained primarily large caliber lumenized ves-
sels that contained blood cells (Figure 3A,B). Both wild
type and EC-N1ICD embryos had a range of yolk sac
vessel diameter. However, in wild type yolk sac a major-
ity of the vessels measured consisted of small capillaries,
while in the EC-N1ICD yolk sac a larger proportion of
vessels consisted of a larger cross-sectional area. In EC-
N1ICD yolk sac, approximately 36% of vessels measured
had an area of 16000 μm
2 or greater, while in wild type
yolk sac only 5% measured this size (Figure 3E). This
enlarged vessel phenotype in response to Notch activa-
tion was observed in other sites of vessel differentiation
in the developing embryo. The dorsal aortae (DA) of
EC-N1ICD embryos were approximately twice the
cross-sectional area of wild type embryos (Figure 3C,D,
asterisks). The embryo-derived vasculature of the pla-
centa of EC-N1ICD embryos did invade into the labyr-
inth layer of the placenta (Figure 3G, arrowheads), but
exhibited greatly enlarged vessel diameter (Figure 3G,
arrows). The EC-Rbpj-KO embryos exhibited a decrease
Figure 2 D e f e c t si ng r o w t ha n dy o l ks a cv a s c u l a t u r e
remodeling in EC-N1ICD and EC-Rbpj-KO embryos. (A-C) Lateral
view of E9.5 wild type (A), EC-N1ICD (B), and EC-Rbpj-KO (C)
embryos. EC-N1ICD and EC-Rbpj-KO embryos were smaller in size
than the wild type and exhibited cardiovascular defects. (D-F) Whole
mount E9.5 wild type (D), EC-N1ICD (E), and EC-Rbpj-KO (F) embryos
with surrounding yolk sac. The EC-N1ICD and EC-Rbpj-KO yolk sac
lacked the large, well-defined blood vessels seen in the wild type.
The blood in the EC-N1ICD yolk sac collected near the attachment
to the placenta. (G-I) Immunofluorescence image of E9.5 wild type
(G), EC-N1ICD (H) and EC-Rpbj-KO (H) yolk sac visualized with an
antibody to PECAM1. Wild type embryos showed a remodeled yolk
sac vasculature, with both large and small caliber vessels. The EC-
N1ICD yolk sac did not exhibit branching; all vessels were of a large
caliber. The EC-Rbpj-KO yolk sac also failed to show vascular
remodeling, although all vessels were of a small caliber. Scale bars
are 500 μm (A-C), 1 mm (D-F) and 100 μm (G-I). Arrows (G-I),
avascular inter-vessel space. Asterisk (G), capillary collapse.
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malformations [26]. EC-Rbpj-KO embryonic-derived
vasculature of the placenta was also reduced in size
and did not invade the labyrinth layer of the placenta
(Figure 3H, arrow). Immunostaining of E9.5 wild type
and EC-N1ICD embryos using anti-SMA, indicated that
the dorsal aortae of wild type are surrounded by smooth
muscle cells, while the EC-N1ICD did not recruit any
SMA-positive cells to the dorsal aorta [27] (Figure 3F,G).
The morphological analyses of the models of altered
Notch signaling were consistent with previous analysis
of Notch function in the vasculature [10,17,18,26].
These results point to multiple roles for Notch signaling
in the formation of both the intra- and extraembryonic
vasculature, including the remodeling of the yolk sac
vasculature, the regulation of vessel diameter, and the
invasion of the fetal vasculature into the labyrinth layer
of the placenta.
Identification of Notch regulated genes in EC-N1ICD yolk
sac and EC-Rbpj-KO yolk sac
Gene expression defects in the Notch models were
examined to determine potential molecular mechanisms
of how altered Notch disrupts vascular differentiation,
through altered expression of putative Notch targets.
RNA from yolk sacs of E9.5 wild type, EC-N1ICD and
EC-Rbpj-KO embryos (resulting from a cross with Tie2-
Cre or Flk1-Cre mice) was isolated for gene expression
analysis via microarray and semiquantitative RT-PCR.
W h o l eg e n o m em i c r o a r r a yi d e n t i f i e dal a r g en u m b e ro f
Figure 3 Defects in vessel diameter in EC-N1ICD and EC-Rbpj-KO embryos. Histological sections (lateral) of PECAM1 and NFR-stained E9.5
yolk sac (A, B) and embryos (C, D) at the level of the heart. The wild type yolk sac contained both large and small caliber vessels (A,
arrowheads). The EC-N1ICD yolk sacs contained primarily large caliber vessels (B, arrowheads), however they were lumenized. The dorsal aortae
of the EC-N1ICD embryos (D, asterisk) were approximately twice the area of wild type dorsal aortae (C, asterisk). (E) Distribution of vessel area in
the yolk sac of wild type and EC-N1ICD embryos. Both wild type and EC-N1ICD embryos had an array of differently sized vessels. However, wild
type yolk sac had a majority of vessels with an area of 0-4000 μm
2, while EC-N1ICD contained many vessels with an area of 30000 μm
2 or
greater. (F, G) Histological sections of E9.5 dorsal aorta stained with an antibody to smooth muscle a-actin. The dorsal aortae of the wild type
contain SMA-positive cells (F), while the EC-N1ICD dorsal aortae are SMA-negative. (H-J) Histological sections of the placental vasculature in wild
type (H), EC-N1ICD (I), and EC-Rbpj-KO (J) embryos. Blood vessels containing nucleated erythrocytes in EC-N1ICD placenta (I, arrow) were of
larger caliber than blood vessels in wild type placenta (H, arrow). In both, the fetal vasculature invaded into the maternal portion of the placenta.
The vessels of the EC-Rbpj-KO placenta (J, arrow) were small in size and had not invaded into the labyrinthine layer. Asterisk (H-J), maternal
blood. Scale bars are 100 μm (A-D).
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which were confirmed with RT-PCR (Figure 4). To
identify putative Notch targets, genes were categorized
on the altered response in the gain-of-function and loss-
of-function models (Additional File 3). Only a relatively
small set of genes displayed upregulation in the EC-
N1ICD model and downregulation in the EC-Rbpj-KO
model, which would be suggestive of genes that are
positively regulated by the Notch1-Rbpj axis. Interest-
ingly, no genes were identified as being downregulated
in the EC-N1ICD model and upregulated in EC-Rbpj-
KO (Additional File 3).
The members of the Hairy/Enhancer of split-related
(HES/HEY) family are well described Notch targets,
many of which are directly regulated by Notch1 signal-
ing via its binding to RBPJ [28] to regulatory regions of
these loci. The microarray datasets revealed that in yolk
sacs of EC-N1ICD embryos, both Hey1 and Heyl were
highly induced, and expression of these genes was
reduced in the EC-Rbpj-KO; these results were con-
firmed by semi-quantitative RT-PCR (Figure 4A).
Expression of Hey1 and Heyl was increased 4.4-fold and
20.5-fold in the EC-N1ICD model respectively, and
decreased to 35% and 46% of wild type levels in the EC-
Rbpj-KO yolk sac tissue, respectively. Interestingly, the
expression of other HES family members, such as Hes1
and Hes6 was not affected in these Notch models (data
not shown), consistent with a context-dependent regula-
tion of Notch targets [29,30]; i.e. Notch signaling
invokes distinct downstream targets depending on both
the cell type and the local environment.
The expression of the endogenous Notch ligands and
receptors was also examined in detail. Previous work
has suggested a potential autoregulatory loop for Notch
signaling in the control of ligands and receptors [31,32].
Although expression of the Notch family receptors was
not altered in either the EC-N1ICD or EC-Rbpj-KO
yolk sacs, the Notch ligands Delta-like 4 (Dll4)a n d
Jagged 1 (Jag1) showed higher expression in EC-N1ICD
(2.5-fold and 2.0-fold, respectively) with little or no
change in expression in EC-Rbpj-KO yolk sac. These
findings point to specific Notch pathway targets in the
extraembryonic yolk sac vasculature.
Notch-Rbpj signaling regulates vascular expression of key
signaling molecules
Given the defects in vessel diameter and remodeling in
response to altered Notch activity, we wished to focus
gene expression analysis on secreted factors. Genes
encoding several known and putative secreted factors
were differentially expressed in the Notch models (Addi-
tional File 4). Expression defects of a subset of these
g e n e sw e r ec o n f i r m e dv i aR T - P C R ,w i t haf o c u so n
genes with putative roles in vascular differentiation and
that display coordinate defects in expression in the
EC-N1ICD and EC-Rbpj-KO models. Although the
expression of some VEGF family members was not sig-
nificantly different in yolk sac, the microarray datasets
indicated that expression of the VEGF family members
Vegfc, encoding VEGF-C, and Pgf, encoding Placenta
Growth Factor (PlGF), were both increased in
EC-N1ICD and Vegfc was decreased in EC-Rbpj-KO
(Additional File 4). RT-PCR confirmed that Vegfc was
upregulated 2.6-fold in the EC-N1ICD and decreased to
8% in the EC-Rbpj-KO compared to control yolk sac tis-
sue; Pgf was upregulated 1.9-fold in the EC-N1ICD and
decreased to 74% in the EC-Rbpj-KO compared to con-
trol yolk sac tissue. The secreted cytokine Tgfb2 also
exhibited increased expression in the yolk sacs of
EC-N1ICD yolk sac tissue (4.7-fold) and decreased
expression in EC-Rbpj-KO (49% of wild type levels)
(Figure 4B).
Given that the N1ICD was activated specifically in the
endothelia in this transgenic model, we wished to con-
firm that the gene expression defects in this model are
confined to the endothelial lineage, to determine if the
gene expression defects are intrinsic to the endothelium,
or are associated with another cell type within the yolk
sac. To these ends, gene expression of Notch regulated
genes was examined in endothelial cells purified via flow
cytometry. Via fluorescent activated cell sorting (Addi-
tional File 5), PECAM1 + cells were isolated from disso-
ciated yolk sacs of E9.5 wild type or EC-N1ICD
embryos (from a cross with Flk1-Cre mice) and RNA
was isolated from the purified cells for gene expression
analysis via real time PCR. To confirm the enrichment
of sorted endothelial cells within the PECAM1+ popula-
tion, expression of lineage markers were compared
between RNA from purified PECAM1+ cells and from
whole unsorted wild type yolk sac tissue. Endothelial
specific genes such as Cdh5 (VE-cadherin)a n dPecam1
exhibited significant enrichment in PECAM1+ cells (5.7-
fold and 6.7-fold respectively). In contrast, the levels of
the primitive visceral endodermal marker Rhox5 (Pem)
[33] were reduced to 10% in the sorted cells compared
t ow h o l ew i l dt y p ey o l ks a ctissue (Figure 5A), demon-
strating a substantial reduction of visceral endoderm
cells in the purified endothelial cells. These findings
demonstrate a specific enrichment of yolk sac endothe-
lial cells via flow sorting.
The Notch-responsive genes identified in the previous
analysis of whole yolk sac tissues were then examined in
the sorted yolk sac endothelial cells. The endothelial
marker, Pecam1 exhibited statistically equivalent expres-
sion between the EC-N1CD and wild type sorted cells,
similar to that seen in whole yolk sac tissues (data not
shown). However, expression of Hey1 and Heyl was
increased 4.4-fold and 16.7-fold in the EC-N1ICD sorted
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members Vegfc and Pgf were upregulated 2.1-fold and
1.9-fold, respectively in sorted EC-N1ICD endothelial
cells compared to wild type, while Tgfb2 was increased
6.9-fold (Figure 5B). These results demonstrate that the
expression of these genes is upregulated specifically in
the endothelial lineages in EC-N1ICD yolk sac. Taken
together, the gene expression defects demonstrate that
Notch-Rbpj signaling acts to regulate many key genes
specifically in the endothelia of the developing yolk sac.
The misexpression of some of these factors may contri-
bute to the vascular differentiation defects seen in the
transgenic models.
Putative Notch regulated genes contain potential RBPJ
binding sites in the upstream regulatory region
The in vivo studies have identified a number of putative
Notch regulated genes in the developing vasculature.
Many of these genes are known Notch targets, including
Hey1 and Heyl, with known RBPJ binding sites within
regulatory elements [28]. These studies however also
identified altered expression of several genes, including
Vegfc, Tgfb2,a n dPgf, for which their regulation by Notch
signaling has not previously been described. Bioinformatic
tools were used to determine if these genes are poten-
tially direct targets of Notch signaling through RBPJ. Sev-
eral RBPJ binding sites, with a core consensus binding
sequence GTGGGAA [34], have been previously identi-
fied in known Notch targets such as the HES family
members [28,35]. The bioinformatic tool, ECR browser
[36], was used to determine if canonical RBPJ binding
sites were observed in the promoter proximal regions of
loci encoding the secreted factors, Vegfc, Pgf,a n dTgfb2.
The mouse, human, and rat genomic sequences of each
of the target genes were aligned and examined for the
RBPJ conserved transcription factor binding sites (TFBS)
within the evolutionary conserved regions (ECRs)
upstream and downstream of the start site. In each of the
genes a GTGGGAA consensus sequence was found, indi-
cating a potential RBPJ site (Additional File 6). In the
Vegfc locus, an RBPJ binding site is apparent approxi-
mately 7.8kb upstream of the start site, while the Pgf
locus harbors an RBPJ binding site 4.1kb upstream and
one 3.8kb downstream of the transcriptional start site.
RBPJ sites were observed at approximately 2.5kb and
5.8kb upstream of the start site of the Tgfb2 locus. The
putative Notch binding sites in each gene suggests that
these genes may be direct targets of Notch signaling.
Discussion
Numerous studies have indicated critical roles for Notch
signaling in the proper formation and maintenance of
the early vascular system in the mouse. However, the
mechanisms by which Notch signaling regulates such
diverse aspects of endothelial differentiation in its
various contexts are active areas of research. Our analy-
sis details the morphological and molecular defects asso-
ciated with altered Notch signaling in vivo, with a focus
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Page 7 of 14on the extraembryonic vasculature of the yolk sac. This
work has characterized distinct morphological defects in
the early embryonic and extraembryonic vasculature
associated with loss or gain of Notch activity. Substan-
tial gene expression differences in these models point to
putative Notch target genes, and suggest potential
mechanisms by which Notch signaling directs endothe-
lial cell differentiation.
Morphological analysis of both EC-N1ICD and EC-
Rbpj-KO models confirmed that the regulation of Notch
signaling is critical in the formation of the intra- and
extraembryonic vasculature of the developing embryo.
Detailed examination of the yolk sac vasculature, dorsal
aortae, and fetal vasculature of the placenta revealed an
enlarged vessel phenotype in the EC-N1ICD, remarkably
apparent within the yolk sac, in which the plexus is
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Page 8 of 14converted to a mass of large diameter vessels (Figure 6A).
In contrast, small caliber non-remodeled vessels are pre-
sent in the EC-Rbpj-KO yolk sac model (Figure 6A).
Other Notch models have demonstrated malformations
in vessel diameter resulting from altered Notch activity,
including other models of activated Notch in vivo
[18,27]. Notch1 deficient mice [15], mice lacking Rbpj in
the endothelia, and Dll4
+/- embryos [26] each exhibit col-
lapsed dorsal aortae and a lack of vascular remodeling. In
contrast, embryos overexpressing either Dll4 [37] or
Notch4 [17] have enlarged dorsal aortae. Data indicated
that the enlargement of the dorsal aortae in mice overex-
pressing Dll4 was due not to a proliferation of endothelial
cells, but to the improper migration of these cells [26].
These data point to an important role for Notch signaling
to regulate vessel diameter.
Given that Notch signaling is associated with arterial
identity [13,14], this function of Notch signaling to con-
trol vessel size may represent an aspect of Notch func-
tion in the definition of the arteriole. The mechanisms
of how Notch and other signaling pathways control ves-
sel size in the various regions of the developing embryo
are not well defined, and are likely context dependent.
Some models suggest that directional cell division is
important to dictate whether endothelial cell prolifera-
tion within a patent vessel results in an increase in lumi-
nal diameter [38]. Other models suggest the recruitment
of endothelial or angioblast cells into existing vessels as
an important mechanism to increase vessel diameter
[39]. The remodeling process of the yolk sac makes
extensive use of reallocation of cells during remodeling
(discussed below), suggesting complex roles for Notch
signaling in controlling endothelial cell behavior during
remodeling.
The yolk sac vasculature represents a genetically tract-
able model to study endothelial differentiation, and the
work presented here has made extensive analysis of this
tissue. Endothelial differentiation within the yolk sac is
initiated as groups of cells from the proximally situated
extraembryonic mesoderm condense into blood islands
by approximately embryonic day 7.0, which subse-
quently migrate toward the distal region of the yolk sac.
The peripheral cells will differentiate to the endothelial
cells lining the vasculature, whereas the inner cells
become blood cells. The endothelial cells expand and
fuse to form the vascular plexus, which is contiguous
with the embryonic vasculature at the onset of blood
flow [40]. The capillaries are then remodeled into the
hierarchical vascular network of vitelline artery, capil-
laries, and vitelline vein. Observations of vessel remodel-
ing in the yolk sac, particularly in the chick embryo,
suggest that the formation of large diameter vessels is
from pre-existing capillary-derived endothelial cells.
This process involves the collapse of some capillary
microvessels, and the endothelial cells from the capillary
are then recruited into the nascent vessels to result in a
larger diameter vessel (Figure 2G, asterisk). This mode
of remodeling resembles the process of intussusceptive
arborization, which has been suggested to be an efficient
and rapid mode of angiogenesis in a variety of sites [3].
Although Notch signaling does play a significant role in
sprouting angiogenesis [41] in many other contexts, the
remodeling of the yolk sac in the early embryo may not
utilize a sprouting angiogenesis method. Instead, this
early vascular remodeling is a rather distinct vascular
mechanism that is not entirely clear and remains to be
studied in detail.
blood flow Notch, VEGF,
etc signaling
Notch1
Notch
A
B
arteriole
integration
Notch
endoderm
endothelia
VEGF & TGFB
family VEGF
others
blood cell
smooth 
muscle cell
flow?
Figure 6 Notch regulates the expression of key genes and the
remodeling of the yolk sac vasculature. (A) Proposed model
depicts the Notch pathway as a key component in the regulation of
the remodeling of the vasculature. In wild type yolk sac Notch acts
in concert with VEGF and other signaling families to direct the
integration of the endothelial cells into both large and small caliber
vessels. When Notch is activated this integration is increased
leading to very large caliber vessels with limited intra-vascular space.
When Notch activity is abrogated the integration is limited and the
vascular retains the simple unremodeled appearance of the early
vascular plexus. (B) Proposed model of signaling in the endodermal
and endothelial cells of the early yolk sac. Signaling from the
endoderm and regulation from blood flow activates Notch signaling
in select endothelial cells. Notch activates the expression of select
secreted genes that act in both a paracrine and juxtacrine manner
to direct endothelial cell migration and integration within the
developing vasculature.
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the yolk sac plexus, the defects in vessel diameter and
the remodeling failure in the Notch models used in this
study indicate a possible defect in the reallocation of
endothelial cells from capillaries into arterioles, suggest-
ing that Notch plays a significant role in this migration.
The phenotype observed in the EC-N1ICD yolk sac vas-
culature is possibly due to increased mobilization and
disorganized recruitment of capillary-derived endothelial
cells, resulting in a field of enlarged vessels. Conversely
the failure of the yolk sac remodeling in the EC-Rbpj-
KO model is due to the abrogation of endothelial cell
migration to form the larger caliber vessels. Live ima-
ging of the behavior of endothelial yolk sac cells in the
Notch models used in this study will be required to ela-
borate this model.
A detailed understanding of the downstream effectors
of Notch signaling during vascular differentiation in
vivo, particularly within the extraembryonic tissues, has
been lacking. The molecular analysis of the Notch mod-
els presented here identified a variety of gene expression
defects associated with altered Notch activity. Both the
gain- and loss-of-function in vivo models suggest misre-
gulation of a number of genes. Data indicated that two
of the Notch family ligands, Dll4 and Jag1 were upregu-
lated in EC-N1ICD yolk sac, indicating a possible
positive feedback loop for Notch signaling to direct
expression of its ligands. There is some precedence for a
positive regulatory loop in which Notch regulates the
expression of ligands, including Jag1 in NIH 3T3 cells
[31] and Dll1 in glioma cells [32].
Importantly, the gene expression analysis also identi-
fied a number of secreted factors whose expression
within the endothelia is altered in the Notch models.
These data suggest that the Notch signaling pathway
regulates a number of secreted factors important in
endothelial differentiation such as, Pgf, Vegfc,a n dTgfb2,
either directly or indirectly. Targeted deletions of select
TGF-b signaling components in mice result in the
improper formation of the yolk sac vasculature, indicat-
ing the importance for TGF-b signaling in the formation
of the early vascular system [42]. Vegf signaling has cri-
tical early roles in the formation of the blood vessels in
the early embryo [43,44]. VEGF has also been shown to
act as an upstream component of Notch in the signaling
cascade directing the differentiation of the zebrafish vas-
culature [45]. PlGF has known roles in pathological
angiogenesis [46,47], and may act as a VEGF agonist by
countering the effects of the VEGFA antagonist Flt1. In
addition to the essential functions of VEGFC in the
developmental origin of the lymphatic system [48,49],
there is conflicting data to suggest it plays a broader
role in angiogenesis. Although this factor has known
angiogenic activities in certain assays [50], no vascular
defects have been reported in mice lacking Vegfc [48].
The expression of VEGFC within the yolk sac however
suggests a potential non-lymphatic function for this fac-
tor in this tissue. A putative role for VEGFC in angio-
genesis may involve the modulation of its receptors, Kdr
(VEGFR2) and Flt4 (VEGFR3), both of which play a cri-
tical role in early angiogenesis.
Notch signaling is essential for vessel remodeling, as
our data shows that Notch regulates the expression of a
variety of secreted factors. Notch signaling may play
potential nonautonomous roles in the remodeling of the
yolk sac capillary plexus (Figure 6B). Notch signaling is
important for the regulation of select signaling mole-
cules, including members of the VEGF family and TGF-
b family, which would emanate from the developing
arteriole where activity of Notch signaling is highest.
These molecules then act in a paracrine and autocrine
manner to elaborate the local arterial microenvironment
about Notch expressing cells, which may potentially
influence adjacent capillary endothelial cells, smooth
muscle or mural cells, and hematopoietic cells. Indeed,
nonautonomous functions for Notch signaling in the
endothelium have been suggested, including attenuating
proliferation of smooth muscle cells [27]. Testing of the
nonautonomous functions of Notch signaling in the vas-
culature will require determining the roles of Notch-
regulated secreted factors in vivo. These experiments
may include the use of conditional transgenics and
knockouts of these factors in the endothelia, and deter-
mining remodeling and endothelial differentiation
defects in these models.
Yolk sac vessel remodeling occurs after the initiation
of blood flow, which initiates at approximately E8.5 in
the mouse [40], and this flow is essential for the remo-
deling process. It is formally possible that the enlarged
luminal diameter of the dorsal aorta in the Notch gain-
of-function model could give rise to a secondary failure
of yolk sac remodeling solely due to reduced flow and
associated shear stress. However, the vessel architecture
reported in mouse models with remodelling defects
solely due to altered blood flow [40] display very differ-
e n tp h e n o t y p e sf r o mt h o s eo b s e r v e di nt h eN 1 I C D
model. This comparison suggests that the remodeling
defects and some of the associated gene expression
defects in the yolk sac in this Notch1 gain-of-function
model are not secondary to embryonic vessel defects or
defects in blood flow. The cellular and subsequent mole-
cular response to the shear stress associated with blood
flow is not completely understood, but may involve a
complex cell surface signalling molecules including
KDR, PECAM1, and VE-cadherin [51]. Shear stress thus
initiates a molecular cascade in endothelial cells to
direct further morphological changes to direct remodel-
ing. An important questioni sw h a ti st h el i n kb e t w e e n
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essential for vessel remodeling. During remodeling, an
arteriole rudiment is first observed at the site of yolk sac
vasculature contact with the omphalomesentric artery.
Early Dll4 expression is observed at this arteriole rudi-
ment within the yolk sac [52], indicating it is likely the
Notch ligand that initiates Notch activity within this
restricted region of the yolk sac vasculature. It remains
to be seen the extent to which fluid dynamics control
the expression of Notch signalling components and the
subsequent remodeling process.
Conclusions
The transcriptional network controlled by Notch signal-
ing during extraembryonic endothelial differentiation is
largely unknown. The present data demonstrate a role
for Notch signaling in the regulation of a number of key
genes in the embryonic vasculature of the yolk sac,
including a variety of secreted factors important for
endothelial differentiation. These downstream targets
suggest a mechanism for Notch regulation of vessel dia-
meter size during the remodeling process in the yolk sac
vasculature. Further work on the in vivo models will
help to further define the relationship between the tran-
scriptional networks regulated by Notch to direct
endothelial differentiation, and the role of these Notch
downstream targets in endothelial migration and vascu-
lar remodeling. The understanding of these interactions
and processes will aid in the development of treatments
affecting vascular differentiation, including heart disease
and tumor progression.
Methods
Mice and embryos
The generation of Rosa
Notch mice, loxP-flanked Rbpj,
Tie2-Cre and Flk1-Cre mice have been described pre-
viously [21-24]. Tie2-Cre mice and loxP-flanked Rbpj
mice were mated to obtain Tie2-Cre; Rbpj
f/+ males.
Breeding pairs of Tie2-Cre or Flk1-Cre mice and
Rosa
Notch mice or Tie2-Cre; Rbpj
f/+ males and Rbpj
f/+
females were intercrossed and the presence of a vaginal
plug was identified as E0.5. Embryos were dissected
from the decidual tissue at E8.5, E9.5, or E10.5 and trea-
ted according to the intended protocol. Placenta were
separated from the embryo along with the mesometrial
portion of the decidua and prepared for histology. All
experimental procedures were performed with prior
approval of the University Institutional Animal Care and
Use Committee in accordance with guidelines estab-
lished by the American Veterinary Medical Association.
Genotyping of Progeny
The genotypes of all offspring were analyzed by PCR on
genomic DNA isolated from ear punches, yolk sac
samples, or embryonic tissue depending on the intended
protocol. Genomic DNA was isolated using the DNeasy
Blood & Tissue Kit (Qiagen). The Tie2-Cre and Flk1-
Cre transgene presence was tested with the primers
Cre-R3, 5’-AAT GCT TCT GTC CGT TTG-3’ and Cre-
F3, 5’-GGA TTA ACA TTC TCC CAC C-3’, giving a
458-bp band [53]. PCR genotyping for Rosa
Notch mice
was performed as described [25]. The wild type, floxed,
and deleted Rbpj alleles were genotyped as described
[54].
Immunochemistry
Embryos with or without the surrounding yolk sac were
fixed in 4% paraformaldehyde/PBS overnight at 4°C. The
f o l l o w i n gd a yt h e yw e r er i n s e di nP B S ,d e h y d r a t e di n
methanol, and bleached in 1mL of 1.5% H2O2 in metha-
nol for 4-5 hours at room temperature. Embryos were
then rehydrated through methanol into PBS, blocked in
PBSMT (PBS, 3% nonfat dry milk, 0.1% Triton X-100)
for 2 hours at room temperature and incubated with
1:50 anti-PECAM1 antibody (BD Pharmingen) overnight
at 4°C. Embryos were washed 5 times for 1 hour each
with PBSMT and incubated with 1:100 HRP-coupled
anti-rat IgG (#14-16-12, kpl.com) overnight at 4°C.
Embryos were again washed 5 times in PBSMT with a
final wash in PBT (PBS, 0.2% BSA, 0.1% Triton X-100).
Then embryos were incubated in developing solution
(0.3 mg/mL DAB, 0.5% NiCl2 in PBT) for 20 minutes at
room temperature followed by the addition of H2O2 at a
0.03% final concentration. Once the color developed
(approximately 10min.), the embryos were rinsed in
PBT and then PBS and fixed overnight in 2% parafor-
maldehyde/0.1% gluteraldehyde/PBS at 4°C. Embryos
were then rinsed in PBS and either equilibrated into
70% glycerol for imaging or dehydrated in ethanol for
paraffin embedding.
X-gal staining
Untreated whole-mount E8.0 and E8.5 embryos with
surrounding yolk sac were fixed on ice for 10 min in a
fixation solution. The samples were then washed
3 times in 1X PBS pH 7.4 and stained overnight at 37°C
per established procedures [55]. The next day, the sam-
ples were rinsed in PBS and fixed overnight in a 3.7%
paraformaldehyde/PBS solution. The following day, the
samples were again rinsed, imaged and stored in 70%
EtOH for paraffin embedding.
Histology
Untreated whole-mount embryos, whole-mount
PECAM1 stained embryos and placenta were fixed in
3% paraformaldehyde overnight, dehydrated into 70%
ethanol and embedded in paraffin wax. Embryos were
then sectioned on the transverse generally in 8 μm
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Eosin or Nuclear Fast Red staining was conducted on
the paraffin sections and sections were observed.
Preparation of single yolk sac cell suspension
E9.5 embryos were obtained from timed matings
between Flk1-Cre females and Rosa
Notch males. Yolk sacs
were incubated in 0.1% collagenase (StemCell Technolo-
gies Inc)/phosphate-buffered saline (PBS)/20% fetal
bovine serum at 37°C for 30 minutes. The digested yolk
sacs were aspirated through 27-gauge needles to fully
separate the cells. Genotyping was performed on DNA
isolated from corresponding embryo tissues.
Cell sorting with PECAM1 and analysis of PECAM1+ cells
Single-cell suspensions from yolk sacs were incubated
for 30 minutes at 4°C with anti-PECAM1 antibody con-
jugated to phycoerythrin cyanine 7 (eBioscience Inc).
The PECAM1+ cells were isolated by cell sorting with
the use of a BD FACSAria cell sorter (BD Biosciences).
Total RNA was isolated from the sorted cells using an
RNeasy mini kit (Qiagen) and RNA was used for real
time PCR analysis.
RT-PCR analysis
Embryos were dissected at E9.5. The uterus and decidua
were carefully removed and discarded. The yolk sac was
separated from the embryo and the embryo was used
for genotyping. Total RNA was isolated from the yolk
sac using an RNeasy mini kit (Qiagen). cDNA was gen-
erated using SuperScript III reverse transcriptase (Invi-
trogen). Semiquantitative RT-PCR was performed using
a number of primers from IDT (idtdna.com) (Additional
File 7), with ribosomal protein L7 (5’-GAA GCT CAT
CTA TGA GAA GGC-3’ and 5’-AAG ACG AAG GAG
CTG CAG AAC-3’) as a control. The annealing tem-
perature and number of PCR cycles was optimized for
each reaction.
Real Time PCR
RNA was isolated from sorted endothelial cells using an
RNeasy mini kit (Qiagen). cDNA from endothelial cells
was generated using Superscrpit III reverse transcriptase
(Invitrogen) and quantitative real-time PCR analysis was
performed using Taqman primer sets with the 7500
Real Time PCR system (Applied Biosystems). Gene
expression was normalized to GAPDH. Specific ABI
Taqman primer/probe assay IDs are available upon
request.
Microarray Analysis
RNA was isolated from yolk sac tissues using an RNeasy
mini kit (Qiagen). RNA was initially analyzed with the
Mouse Genome 430 A Array from Affymetrix. Microarray
data was deposited to the Gene Expression Omnibus
(GSE22418).
Yolk sac immunofluorescence
Embryos were dissected at E9.5 in PBS. The uterus and
decidua were carefully removed and discarded. The yolk
sac was separated from the embryo by severing the vitel-
line arteries and the embryo was used for genotyping.
The yolk sacs were collected in separate wells of a 24
well plate and then fixed in 1mL of 3% paraformalde-
hyde/PBS for 15 minutes on ice. Then the yolk sacs
were permeabilized in 1mL of PBS containing 0.02%
Triton X-100 for 30 minutes. Yolk sacs were transferred
to separate 1.5mL Epindorf tubes containing 500uL of
blocking solution (PBS,3 %B S A ,5 %d o n k e ys e r u m
(Jackson ImmunoResearch)) for 2 hours at room tem-
perature. Blocking solution was changed once at 1 hour.
Yolk sacs were then incubated with 1:33 anti-PECAM1
antibody (#557355, BD Pharmingen) overnight at 4°C.
Embryos were washed 5 times for 1 hour each with
blocking solution and incubated with 1:75 FITC-conju-
gated AffiniPure Anti-Rat IgG (#712-095-153, Jackson
ImmunoResearch) overnight at 4°C. Embryos were again
washed 5 times in blocking solution with a final 20-min-
ute wash in PBS. The yolk sacs were transferred via Pas-
teur pipette to a drop of SlowFade Gold antifade
reagent (Molecular Probes) on a glass slide and covered
with a cover slip.
Histology Immunofluorescence
Embryos were prepared following the above protocol
for histology. Tissues were deparrafinized through
xylene and EtOH into cold tap water. Antigen retrieval
was performed by immersing the slides in 10 mM cal-
cium citrate for 20 minutes in a steam chamber. Sec-
tions were washed first with water and then 2 times
with PBS. Sections were then incubated in PBT (PBS,
0.2% BSA, 0.1% Triton X-100) for 2 hours at room
temperature. Sections were stained with a-smooth
muscle actin (1:250 dilution; catalog no. A2547; Sigma-
Aldrich, Inc) for 1 hour at 4°C. Sections were washed
3 times with PBT and then stained with Alexa Fluor
546 goat anti-mouse IgG (1:250 dilution; catalog no.
A11003; Invitrogen) for 30 minutes at room tempera-
ture in the dark. Sections were again washed 3 times
with blocking solution. A small amount of ProLong
Gold antifade reagent with DAPI (Invitrogen) was
applied and the samples were covered with a cover
slip, allowed to set, and imaged. Slides were stored at
-20°C.
Identification of TFBSs
The ECR browser [36] was used to determine the loca-
tion of potential RBPJ binding sites. The evolutionary
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examined upstream and flanking the transcription start
site of each gene for the presence of the RBPJ binding
sequence (GTGGGAA) [34].
Microscopy and image acquisition
Images were acquired with a Nikon SMZ800 dissecting
microscope for whole embryos and a Nikon ECLIPSE
55i for embryonic sections using a Leica DFC480 cam-
era and Leica FireCam 3.0 software. Images for yolk sac
immunofluorescence were acquired with an Olympus
1X71 microscope and Olympus DP71 camera using
Olympus DP71 controller software. Adobe Photoshop
CS2 was used for photograph editing.
Statistical Analysis
Data bars represent the means +/- standard error of the
mean. RNA analyses of yolk sac tissues were performed
with an n of 5. The statistical significance of the data
was determined using a t-test with a p-value of < 0.05
considered statistically significant.
Additional material
Additional file 1: Tie2-Cre and Flk1-Cre are expressed in the
endothelia of the early embryo. (A-E) X-Gal staining of embryos from
R26R cross with Tie2-Cre transgene. (A-C) Whole mount E8.5 embryos. (D,
E) Histological sections of E8.5 embryos. (F-I) X-Gal staining of embryos
from R26R cross with Flk1-Cre transgene. (F) Whole mount E8.0 embryo
with surrounding yolk sac. (G) Whole mount E8.5 embryo. (H) Yolk sac
from a E8.5 embryo. (I) Histological section of E8.5 embryo. Note
expression in the endothelia of dorsal aorta (DA), heart (He), anterior
cardinal vein (ACV), yolk sac (YS), allantois (Al), lateral plate (LP), and
vitelline artery (VA).
Additional file 2: Embryonic growth and vascular remodeling is
normal in early EC-N1ICD embryos. (A, B) Whole mount E8.5 wild type
(A) and EC-N1ICD littermate (B) embryos with surrounding yolk sac
stained with an antibody to PECAM1. EC-N1ICD yolk sac vasculature
appeared normal. (C, D) Lateral view of E8.5 wild type embryo (C) and
EC-N1ICD littermate (D) stained with an antibody to PECAM1. EC-N1ICD
embryos appeared normal. Scale bars are 500 μm (A, B) and 250 μm (C,
D).
Additional file 3: Gene expression in EC-N1ICD and EC-Rbpj-KO yolk
sac tissues. A graphical representation of possible outcomes of
expression data and the corresponding genes that display this type of
expression.
Additional file 4: Expression of genes encoding secreted factors in
EC-N1ICD and EC-Rbpj-KO yolk sac tissues
Additional file 5: Histograms obtained from PECAM1-PE Cy7
fluorescent activated cell sorting. Representative histograms showing
the distribution of dissociated yolk sac cells for the (A) isotype control
and PECAM1 stained (B) wild type yolk sac and (C) EC-N1ICD yolk sac.
The gating used to purify PECAM1+ cells is indicated.
Additional file 6: rVista visualization of conserved RBPJ binding
sites. Using the ECR browser, the genomic sequence of each of the
three secreted genes, Vegfc, Pgf, and Tgfb2 was examined for the RBPJ
binding site. The red bars identify the resulting binding sites.
Additional file 7: Primer pairs used for RT-PCR
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